Stock Split Watch: Lilly — Is Eli Lilly Next to Split?
Eli Lilly has been a standout growth stock thanks to GLP-1 drug demand. Could a stock split be on the horizon? This g...
This intro compares merchant acceptance for BTC and ETH, outlining where each is more commonly accepted by merchants.
27,224 articlesEli Lilly has been a standout growth stock thanks to GLP-1 drug demand. Could a stock split be on the horizon? This g...
Berkshire Hathaway isn’t just a cash hoard. The true driver is a sophisticated insurance float that funds growth with...
Solana is rapidly gaining ground in decentralized finance thanks to speed and low costs. This article explores a prac...
Aehr Test Systems faces a pivotal Q4 print after the market closes, with AI burn-in demand and bookings in focus as t...
Datadog's CEO recently sold a sizable block of shares. This article breaks down the numbers, explains why insiders se...
Procter & Gamble has built a remarkable dividend-growth legacy, raising payouts for seven decades. This article break...
Bitwise CIO Matt Hougan contends this crypto winter much healthier than prior cycles, pointing to stronger on-chain a...
As gold markets swing in 2026, the hidden danger leveraged gold ETFs face becomes clear: daily resets amplify losses ...
AAPD’s 3.43% yield looks appealing, but the bear-on-Apple fund relies on collateral interest instead of dividends. A ...
Warren Buffett's looming Berkshire Hathaway exit plans could reshape both philanthropy and investing. This analysis e...
Nike has steadied after a challenging period, yet investors should brace for the real test: translating a stabilized ...
Oracle's shares have fallen steeply as AI hype cooled. This article breaks down whether the stock is a value opportun...